Pre-transplant reversible pulmonary hypertension predicts higher risk for mortality after cardiac transplantation

Journal of Heart and Lung Transplantation

Volumn 24, Issue 2, 2005, Pages 170-177

  Butler, Javed ^a,b   Stankewicz, Mark A ^a   Wu, Jack ^a   Chomsky, Don B ^a,b   Howser, Renee L ^a   Khadim, Ghazanfar ^a   Davis, Stacy F ^a   Pierson III, Richard N ^c   Wilson, John R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BODY MASS; DIASTOLIC BLOOD PRESSURE; DONOR; FEMALE; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HEMODYNAMICS; HUMAN; LUNG ARTERY PRESSURE; LUNG PRESSURE; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MORTALITY; PREDICTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RECIPIENT; STERNOTOMY; SYSTOLIC BLOOD PRESSURE;

EID: 13444262284     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2003.09.045     Document Type: Article

References (31)

1. Butler J., Chomsky D.B., Wilson J.R. Pulmonary hypertension and exercise intolerance in patients with heart failure. J Am Coll Cardiol. 34:1999;1802-1806
2. Abramson S.V., Burke J.F., Kelly J.J. Jr, et al. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med. 116:1992;888-895
3. Ghio S., Gavazzi A., Campana C., et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol. 37:2001;183-188
4. Kirklin J.K., Naftel D.C., Kirklin J.W., Blackstone E.H., White-Williams C., Bourge R.C. Pulmonary vascular resistance and the risk of heart transplantation. J Heart Transplant. 7:1988;331-336
5. Costard-Jackle A., Fowler M.B. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group. J Am Coll Cardiol. 19:1992;48-54
6. Costanzo M.R., Augustine S., Bourge R., et al. Selection and treatment of candidates for heart transplantation. A statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation. 92:1995;3593-3612
7. Baim D.S.G.W. Cardiac catheterization, angiography, and intervention. 1996;Williams & Wilkins, Baltimore, MD
8. Tenderich G., Koerner M.M., Stuettgen B., et al. Does preexisting elevated pulmonary vascular resistance (transpulmonary gradient >15 mm Hg or >5 wood) predict early and long-term results after orthotopic heart transplantation? Transplant Proc. 30:1998;1130-1131
9. Cockcroft D.W., Gault M.H. Prediction of creatinine clearance from serum creatinine. Nephron. 16:1976;31-41
10. Costard-Jackle A., Hill I., Schroeder J.S., Fowler M.B. The influence of preoperative patient characteristics on early and late survival following cardiac transplantation. Circulation. 84:1991;III-329-III-337
11. O'Connell J.B., Bourge R.C., Costanzo-Nordin M.R., et al. Cardiac transplantation recipient selection, donor procurement, and medical follow-up. A statement for health professionals from the Committee on Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation. 86:1992;1061-1079
12. Baldovinos A., Kalangos A., Sierra J., Licker M.J., Faidutti B. Is partially reversible pulmonary hypertension a contraindication for heart transplantation? Transplant Proc. 32:2000;468-469
13. Erickson K.W., Costanzo-Nordin M.R., O'Sullivan E.J., et al. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation. J Heart Transplant. 9:1990;526-537
14. Bourge R.C., Naftel D.C., Costanzo-Nordin M.R., et al. Pretransplantation risk factors for death after heart transplantation a multi institutional study. The Transplant Cardiologists Research Database Group. J Heart Lung Transplant. 12:1993;549-562
15. Lindelow B., Andersson B., Waagstein F., Bergh C.H. High and low pulmonary vascular resistance in heart-transplant candidates. A 5-year follow-up after heart transplantation shows continuous reduction in resistance and no difference in complication rate. Eur Heart J. 20:1999;148-156
16. Murali S., Kormos R.L., Uretsky B.F., et al. Preoperative pulmonary hemodynamics and early mortality after orthotopic cardiac transplantation the Pittsburgh experience. Am Heart J. 126:1993;896-904
17. Tenderich G., Koerner M.M., Stuettgen B., et al. Pre-existing elevated pulmonary vascular resistance long-term hemodynamic follow-up and outcome of recipients after orthotopic heart transplantation. J Cardiovasc Surg. 41:2000;215-219
18. Hosenpud J.D., Bennett L.E., Keck B.M., Boucek M.M., Novick R.J. The Registry of the International Society for Heart and Lung Transplantation eighteenth Official Report - 2001. J Heart Lung Transplant. 20:2001;805-815
19. Delgado J.F., Gomez-Sanchez M.A., Saenz de la Calzada C., et al. Impact of mild pulmonary hypertension on mortality and pulmonary artery pressure profile after heart transplantation. J Heart Lung Transplant. 20:2001;942-948
20. Carrier M., Rivard M., Latter D., Kostuk W. Predictors of early mortality after heart transplantation the Canadian transplant experience from 1981 to 1992. The CASCADE investigators. Canadian Study of Cardiac Transplant Atherosclerosis Determinants. Can J Cardiol. 14:1998;703-707
21. McCarthy J.F., McCarthy P.M., Massad M.G., et al. Risk factors for death after heart transplantation does a single-center experience correlate with multicenter registries? Ann Thorac Surg. 65:1998;1574-1578
22. Levine T.B., Levine A.B., Goldberg A.D., et al. Acute reversibility of pulmonary hypertension predicts neither long-term hemodynamic response nor outcome in patients awaiting heart transplantation. Am J Cardiol. 79:1997;105-106
23. Espinoza C., Manito N., Roca J., et al. Reversibility of pulmonary hypertension in patients evaluated for orthotopic heart transplantation importance in the postoperative morbidity and mortality. Transplant Proc. 31:1999;2503-2504
24. Kirsch M., Baufreton C., Naftel D.C., Benvenuti C., Loisance D.Y. Pretransplantation risk factors for death after heart transplantation the Henri Mondor experience. J Heart Lung Transplant. 17:1998;268-277
25. Chen J.M., Levin H.R., Michler R.E., Prusmack C.J., Rose E.A., Aaronson K.D. Reevaluating the significance of pulmonary hypertension before cardiac transplantation determination of optimal thresholds and quantification of the effect of reversibility on perioperative mortality. J Thorac Cardiovasc Surg. 114:1997;627-634
26. Bourge R.C., Kirklin J.K., Naftel D.C., White C., Mason D.A., Epstein A.E. Analysis and predictors of pulmonary vascular resistance after cardiac transplantation. J Thorac Cardiovasc Surg. 101:1991;432-444
27. Bhatia S.J., Kirshenbaum J.M., Shemin R.J., et al. Time course of resolution of pulmonary hypertension and right ventricular remodeling after orthotopic cardiac transplantation. Circulation. 76:1987;819-826
28. Addonizio L.J., Gersony W.M., Robbins R.C., et al. Elevated pulmonary vascular resistance and cardiac transplantation. Circulation. 76:1987;V52-V55
29. Pamboukian S.V., Carere R.G., Webb J.G., et al. The use of milrinone in pre-transplant assessment of patients with congestive heart failure and pulmonary hypertension. J Heart Lung Transplant. 18:1999;367-371
30. Sajkov D., Wang T., Frith P.A., Bune A.J., Alpers J.A., McEvoy R.D. A comparison of two long-acting vasoselective calcium antagonists in pulmonary hypertension secondary to COPD. Chest. 111:1997;1622-1630
31. Packer M., O'Connor C.M., Ghali J.K., et al. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med. 335:1996;1107-1114